E2F1 can increase ccRCC cell proliferation and epithelial–mesenchymal transition (EMT) and promote tumor progression of a mouse xenograft model by inhibiting SREBP-1-mediated aberrant lipid metabolism (128). The gene discussed is SREBF1; the disease is nonpapillary renal cell carcinoma.